The previously unknown cause of anti-phosphatidylethanolamine (aPE) autoimmunity was discovered in a Northwestern Medicine study published in PNAS.
Northwestern Medicine scientists uncovered the molecular process behind a buildup of toxic proteins in Parkinson’s patients, a discovery that may lead to improved therapies.
Northwestern Medicine scientists have identified a guardian molecule triggered by testosterone that appears to protect males from multiple sclerosis.
Northwestern Medicine scientists have discovered mutations that cause improper drainage and a buildup of ocular pressure leading to glaucoma, suggesting a path towards future treatments.
Northwestern Medicine scientists have demonstrated that tiny vesicles called exosomes released from non-metastatic melanoma cells trigger an immune response that prevents cancer from spreading throughout the body.
Northwestern Medicine scientists have discovered a protein that acts as an entry point for the Epstein-Barr virus, providing a potential target for future therapies.
Northwestern Medicine scientists showed how enzyme inhibitors might be used to halt a molecular process that can cause neurodegeneration in patients with HIV.
Scientists are one step closer to a stem cell treatment for muscular dystrophy after Northwestern Medicine investigators demonstrated improvements in muscle tissue differentiation in stem cells.
A newly-designed mutant herpes virus provides a strategy for the development of novel herpes virus vaccines.
A new study provides insights into a mechanism underlying Parkinson’s disease and suggests that an existing drug could be employed as a novel treatment.
Notifications